Hapten Sciences Inc., of Memphis, Tenn., has partnered with Particle Sciences Inc., a drug delivery contract development and manufacturing organization, to progress its lead product, a vaccine developed to lessen or eliminate contact dermatitis from poison ivy, oak and sumac exposure, into the clinic.